Abstract
The Hippo pathway coordinates extracellular signals onto the control of tissue homeostasis and organ size. Hippo signaling primarily regulates the ability of Yap1 to bind and co-activate TEA domain (TEAD) transcription factors. Yap1 tightly binds to TEAD4 via a large flat interface, making the development of small-molecule orthosteric inhibitors highly challenging. Here, we report small-molecule TEAD⋅Yap inhibitors that rapidly and selectively form a covalent bond with a conserved cysteine located within the unique deep hydrophobic palmitate-binding pocket of TEADs. Inhibition of TEAD4 binding to Yap1 by these compounds was irreversible and occurred on a longer time scale. In mammalian cells, the compounds formed a covalent complex with TEAD4, inhibited its binding to Yap1, blocked its transcriptional activity, and suppressed expression of connective tissue growth factor. The compounds inhibited cell viability of patient-derived glioblastoma spheroids, making them suitable as chemical probes to explore Hippo signaling in cancer. A small molecule that forms a covalent bond with a conserved cysteine within the palmitate binding pocket of TEADs was found to inhibit the TEAD⋅Yap protein-protein interaction through allostery. The compound inhibited TEAD transcriptional activity in mammalian cells and blocked patient-derived glioblastoma cell viability.
Original language | English (US) |
---|---|
Pages (from-to) | 378-389.e13 |
Journal | Cell chemical biology |
Volume | 26 |
Issue number | 3 |
DOIs | |
State | Published - Mar 21 2019 |
Externally published | Yes |
Keywords
- allosteric inhibitors
- covalent inhibitors
- Hippo signaling
- protein-protein interaction inhibitors
- small-molecule inhibitors
- TEAD transcription factor
- Yap co-activator
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Drug Discovery
- Clinical Biochemistry